Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cacciari

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 10, 2001
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studiesP G Baraldi, B Cacciari, S Moro, et al.
Journal of Medicinal Chemistry|March 1, 1996
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonistsP G Baraldi, B Cacciari, G Spalluto, et al.
Journal of Medicinal Chemistry|December 2, 1999
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonistsP G Baraldi, B Cacciari, R Romagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|July 2, 1998
Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivityP G Baraldi, B Cacciari, A Guiotto, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptorsP G Baraldi, B Cacciari, R Romagnoli, et al.
Molecular Pharmacology|April 25, 2000
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptorsK Varani, S Merighi, S Gessi, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 30, 2000
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1P G Baraldi, B Cacciari, A Guiotto, et al.
Anti-Cancer Drug Design|November 20, 1997
Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesinP G Baraldi, B Cacciari, R Romagnoli, et al.
Journal of Medicinal Chemistry|February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptorsP G Baraldi, B Cacciari, G Spalluto, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybridP G Baraldi, B Cacciari, A Guiotto, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 10, 2001
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studiesP G Baraldi, B Cacciari, S Moro, et al.
Journal of Medicinal Chemistry|March 1, 1996
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonistsP G Baraldi, B Cacciari, G Spalluto, et al.
Journal of Medicinal Chemistry|December 2, 1999
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonistsP G Baraldi, B Cacciari, R Romagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|July 2, 1998
Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivityP G Baraldi, B Cacciari, A Guiotto, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptorsP G Baraldi, B Cacciari, R Romagnoli, et al.
Molecular Pharmacology|April 25, 2000
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptorsK Varani, S Merighi, S Gessi, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 30, 2000
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1P G Baraldi, B Cacciari, A Guiotto, et al.
Anti-Cancer Drug Design|November 20, 1997
Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesinP G Baraldi, B Cacciari, R Romagnoli, et al.
Journal of Medicinal Chemistry|February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptorsP G Baraldi, B Cacciari, G Spalluto, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybridP G Baraldi, B Cacciari, A Guiotto, et al.
Pageof 4